Literature DB >> 26411957

Management of Gestational Trophoblastic Diseases-An Update.

Dipanwita Banerjee, Salil D Barsode, Partha Basu1.   

Abstract

INTRODUCTION: Gestational trophoblastic disease is a spectrum of neoplastic abnormalities arising from fetal trophoblastic tissue. The range of the diseases in this group varies from relatively benign Hydatidifom mole (complete and partial mole) to highly malignant choriocarcinoma.
METHODS: We have reviewed the available literature and discussed the management and follow up based on the current understanding of the natural history, extent and the prognosis of the disease. Key observations: Depending on the underlying pathology the disease can subside, progress or even metastasize and lead to death, if left untreated. The treatment of the disease is relatively simple and the disease is highly curable by single or multi agent chemotherapy. Appropriate and timely treatment not only saves the women from morbidity and death but also can help preserve their fertility.
CONCLUSIONS: Management of Gestational disease should ideally be done in a specialized multi-disciplinary environment and the outcome of treatment in majority of the cases is very satisfactory.

Entities:  

Mesh:

Year:  2015        PMID: 26411957     DOI: 10.2174/1574887110666150923111731

Source DB:  PubMed          Journal:  Rev Recent Clin Trials        ISSN: 1574-8871


  1 in total

1.  Highly expressed placental miRNAs control key biological processes in human cancer cell lines.

Authors:  Daniel Onofre Vidal; Anelisa Ramão; Daniel Guariz Pinheiro; Bruna Rodrigues Muys; Julio Cesar Cetrulo Lorenzi; Cleidson de Pádua Alves; Dalila Luciola Zanette; Greice Andreotti de Molfetta; Geraldo Duarte; Wilson Araújo Silva
Journal:  Oncotarget       Date:  2018-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.